Bromocriptine mesylate

DRUG2 trials

Sponsors

VeroScience

Conditions

Type 2 Diabetes

Phase 1

Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects

CompletedNCT02078440

VeroScienceType 2 Diabetes

Start: 2014-01-31End: 2016-06-30Updated: 2016-08-29

Phase 3

Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin

TerminatedNCT00441363

VeroScienceType 2 Diabetes

Start: 2005-02-28End: 2006-03-31Updated: 2016-05-09